chrisvoncsefalvay/vaers-outcomes huggingface dataset:
MIGRAINE; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 180502, and batch number: 180502 expiry: UNKNOWN) dose was not reported, administered on 14-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 15-MAR-2021, the subject experienced migraine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of migraine was not reported. This report was non-serious.
Moderna COVID-19 EUA At apporoximately 10pm , 7 day  after being vaccinated, my left arm at the inoculation site became swollen, slightly itchy and moderately  achy.  The next morning, the aching and swelling increased and there was a slight rash.  By 5pm that evening, my arm became more achy, significantly more itchy  and the rash was worse.
Small blister on the inside, left lower lip. No other adverse reaction noted approximately 24 hours post injection.
At 4am, about 12 hours after receiving my first dose of the Moderna vaccine, I woke up to find that I had bled through my pants and bedsheets. I continued to bleed heavily, soaking 3-4 pads (even with a tampon in) every hour until I was able to get ahold of a nurse at my OBGYN clinic. I had called to get in touch with my doctor, but he was not available.  The nurse was concerned by the amount of bleeding, but told me to wait another hour and see if it has slowed down any and call her back. It did not slow down, but I got busy and hadn't called so she reached back out to me at 11am. The nurse told me to go to the emergency room if I got lightheaded, dizzy, or felt weak. She expressed that it was important for me to stay hydrated. I asked her if it could be a side effect from the vaccine and she immediately brushed it off like it was impossible. I have never in my life had this much bleeding before, even after childbirth! I did not feel that the nurse was very professional after that, so I stopped checking in with her. The bleeding slowed down to two pads (and tampons) an hour by the next morning. I continued to soak through two pads an hour the entire next day, September 2nd, and then on September 3rd, it stopped.
After each vaccination only experienced mild GI symptoms for a couple of days: nausea, stomach cramping, diarrhea.    Tested positive at facility to COVID on 12/31/2021.  Moderate symptoms included fever, chills, night sweats, headache, sore throat, fatigue, dry cough, shortness of breath, strong back/rib cage pain.  Lasted a little over 2 weeks, lingering fatigue and back pain for 2 more weeks.  No loss of smell or taste.  Caught a mild head cold in mid February.  Symptoms included stuffy nose, post nasal drip, fatigue.  Recovered very quickly, within a week.  A few days after that, very suddenly had difficulty breathing, with strong back/rib cage pain, constant coughing fits, return of night sweats.  Went to facility on 3/1/22, had X-ray that confirmed no pneumonia, but had ?bronchial changes.?  Was prescribed course of prednisone, doxycycline, albuterol inhaler, cough suppressant.  It?s taken most of March to recover, still have pain when breathing, still have some shortness of breath, lingering fatigue.
Pt recvd pneumococcal vax on 14FEB92 & shortly following vax pt devel purpura from the shoulder to the elbow;
Awoke from sleep at 12:00am (12/30/09) with extreme chills and shaking. Also experienced muscle and joint pain. Slept most of 12/30/09 and still felt sluggish the following day.
My child vomited, became unresponsive, rigid and stopped breathing after a few minutes became conscious again and was rushed to the ER where she was found to have a high temperature 103.7 degrees F.
First and second day: sore arm, sore throat (felt like  lump in throat when swallowing) July 25th: felt excessively more tired than usual July 26th: still felt fatigued during the day.  On July 26th at 9:00 PM, I was in my yard walking my dog when I felt a sudden dizziness and I fell down within what seemed like less than 20 seconds from feeling dizzy.
On day 8 (1-14-21) noticed at injection site a large (avocado size), slightly swollen, bright red patch, noticably warm to the touch.  Deep, mild ache.  Not sore to touch.  Smaller swollen lumps within.  Next day slightly larger, otherwise the same.  Same on day 10 post vaccine (3rd day of rxn).  Now beginning to fade
Myalgia Mild left arm soreness 1 hour after receiving the vaccine and generalized malaise/myalgia Narrative:  Employee reports mild left arm soreness 1 hour after receiving the Vaccine and generalized malaise/myalgia.
Client received flu shot on AM of 9/19/12, started having cold sweat within 1 hr, then felt hot & "like he was going to pass out". Drove home. Called daughter, took temp, in evening when he called prompt care. Temp was 103 degrees. C/O body aches the next day. Flu shot given in RD. C/o redness & swelling at site the night of vaccine.
My forearms, on the back, turned a brownish red in spots.  Thrombocytopenic purpura is what the reference online said it is. Today, Sept. 27th, I still have the splotches, but they are continuing to fade and I have not had new ones since three or four days ago.
This spontaneous report was received from an office manager refers to a patient of unknown age who on 01-OCT-2012, was vaccinated with a dose of RECOMBIVAX HB (lot number 671326/1522AA) (dose and route not reported) that was improperly stored. No symptoms reported. This is one of several reports from the same source. Additional information has been requested.
The second dose of the vaccine series was given one day early on day 20 instead of day 21.
1/4/12 10:35A Pt received HPV shot in (R) deltoid without problem.  Talking & responding appropriately. Flu shot given in (L) deltoid. Pt was talking but stopped suddenly & became very rigid in chair. Skin became very pale & pt did not respond for about 5 sec. LPN came to room & helped to move pt to the floor & elevated feet. Pt started responding while being moved. Responding appropriately. Alert & oriented x 4. Still very pale. C/O slight nausea. States she hasn't eaten this AM. Skin slightly clammy. Cont'd to lie on floor with feet elevated for about 5 minutes. Called Mom & explained what happened. She states she will come pick up pt to take home & rest. Discussed vasovagal responses with mom & things that could help to prevent it from happening. Also instructed her to remind anyone giving her daughter a shot that she could pass out. Talked with NP about incident. 11:20 AM Mom came to clinic to pick up daughter. Pt lying on bed in back room. Walked to room with assistance but tolerated well. Skin pink, W & D. Pt in w/c to go to mom's car. Instructed her to make sure pt eats & drinks when she gets home & to lie around & rest today.
Dizziness, fatigue, scalp sensitivity, "half-body" numbness, arthralgias, fever blister (left lower lip)
Fever 101 F, chills, headache, body aches, joint aches, very low energy, decreased concentration (took 3 days until back to normal)
I had a spike proteins test done on 29Nov2021. The results were I had a number of 5034.4; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 20Jan2021 (Batch/Lot number: unknown) as dose 1, single and administration date 10Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: LABORATORY TEST ABNORMAL (non-serious) with onset 29Nov2021, outcome "unknown", described as "I had a spike proteins test done on 29Nov2021. The results were I had a number of 5034.4". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a health professional concerning an 8 year old male with no known medical history or allergies who in June 1997, was vaccinated SC with a first dose of varicella virus vaccine live (lot 622757/0348E). There was no illness at the time of vaccination. On 3/24/2005 the patient experienced a runny nose and pustules. It was reported that the patient had ten pustules, 3-7 mm in size, on his chest and back. It was reported that he had the runny nose for four days and pustules for two days. On 3/29/2005 the patient recovered. No further information is expected.
DROP DEAD; VERY ILL; This spontaneous report received from a consumer via a company representative via media concerned multiple patients (unspecified number) of an unspecified age, sex, race and ethnicity.   The patient's weight, height, and medical histories were not reported. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry dates were not reported) dose, start therapy dates were not reported, 1 total administered for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patients were very ill and drop dead (death). The cause of death was not reported. It was unspecified if an autopsy was performed. As per reporter, "I have seen too many people drop dead or become very ill after getting the vaccine". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of very ill was not reported. This report was serious (Death).; Sender's Comments: V0- 20221264046- Drop dead. Insufficient information is available to make a causality assessment. Therefore, this event is considered unclassifiable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
After receiving the 1st dose of Pfizer 01/22/2021, started experiencing symptoms 01/25/2021 of loss of vision in the left eye (3 mins). 02/2021 "Silent" Heart Attack diagnosed Blood Clot found in Left ventricle, treatment increased Blood Pressure medication. 11/2021 2 infarcts found in the Visual Cortex, Follow-Up Neurologist Ophthalmologist appt.
Vomitting, fever up to 101 degrees F, lasting roughly 12 hours general fatigue up to 36 hours
This case was reported by a consumer via call center representative and described the occurrence of fever in a 79-year-old female patient who received SHINGRIX for prophylaxis. On 16th June 2018, the patient received SHINGRIX (intramuscular) 50 mcg/mg. On 16th June 2018, less than a day after receiving SHINGRIX, the patient experienced fever, chills and cold. On 17th June 2018, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the chills was not recovered/not resolved and the outcome of the cold was unknown. It was unknown if the reporter considered the fever, chills and cold to be related to SHINGRIX. Additional details were provided as follows: The patient reported that on the day of her SHINGRIX vaccination, she developed a high fever that night that lasted into the next day. The patient also had chills and had been cold ever since the day of her SHINGRIX vaccination.
developed swollen gland, Dizziness and headache. Had client go to Dr and he gave her steroids,  he will follow her and see if he feels she should receive her 2nd dose
Patient is a COVID-19 vaccine breakthrough case. Patient reported being symptomatic from 4/21/2021 to 4/23/2021 and indicated experiencing the following symptoms:  headache, sweats, chills, fatigue, body aches, sore throat, fever (101.0),  and nasal congestion.
Patient is experiencing a red swollen arm that is warm to the touch. She explained that also has a sore throat, head hurts, feels disoriented.
Within 24 Hours: Discomfort at injection site (Lasting 3-4 days); Headache (Lasting approx. 7 days)  Within 36 Hours: Swelling of left armpit lymph nodes (Lasting approx. 1 week); Pain/discomfort in left armpit/side (Lasting approx. 1 week); Chills (Lasting 2-3 days); Body aches (Lasting 2-3 days); Malaise (Lasting approx. 1 week); Low-grade fever (Lasting 2-3 days); Nausea (Lasting 2-3 days)  Treatment: Rest, compression (socks, ace wraps), tylenol, ibuprofen, fluids, elevation  Within 60 Hours: Swelling of the legs (backs and fronts of knees, ankles) (Lasting approx. 10 days); Moderate to severe muscle cramping/spasms (calves, front/back of thighs) (Lasting approx. 10 days); Joint pain (knees, ankles) (Lasting approx. 10 days); Reduced appetite (Lasting approx. 1 week)
today is 14 days after injection, I have a 5 inch in diameter red ring where the injection was given.
Since 12 Feb to present I have had aching bones and joints alone constant fatigue and general weakness in my left arm.
4/11/2021 Had sore arm and headache that did not last entire day.  4/12/2021 Woke up with a sore left eye that is swollen at the bottom of the lid, partial redness.  No drainage, slight sensitivity to light.  Denies vision trouble.  Headache resolved.  Encouraged cool or warm compresses for comfort and to seek medical attention through her eye doctor.
Large reddened area distal to injection site which migrated from the top of my shoulder to my bicep.
Headache, Myalgia, Arthralgia, Fever, chills/ fatigue/ back pain Narrative:
poor pneumococcal vaccine response; Literature report.  A literature article has been received from the authors of a marketed literature article, titled as above, referring to a currently 50 year old male patient. The patient had no history of abnormal immunoglobulin A (IgA) or abnormal immunoglobulin M(IgM) levels. The patient's concomitant medication was not provided.   On an unknown date, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (dose, route, batch/lot# and expiration date were unknown) for prophylaxis.   On an unknown date, the patient showed poor pneumococcal vaccine response (vaccine response impaired). The outcome of poor pneumococcal vaccine response was unknown. The reporter considered the event to be related to pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown).     A copy of the published article has been requested.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 09-FEB-2022; Patient received vaccine past its 30-days expiry date; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30-days expiry date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 09-FEB-2022) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2022 at 3:00 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 09-Feb-2022 at 3:00 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30-days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 09-FEB-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30-days expiry date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 09-FEB-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient ethnicity was reported as White.  No concomitant medications were provided by reporter.  No treatment medications were provided by reporter.  On 09-FEB-2022 at 15:00:57, patient received an expired booster dose.  It was reported that vaccines went into 2-8 C thaw state on or above 24-Dec-2021 and were administered up until the MFG expiry date of 04-Apr-2022.  Prescriptions, over the counter medications, dietary supplements or herbal remedies being taken at time of vaccination or at the time of the adverse event were reported as unknown.  Other vaccines given on the same day as Moderna COVID-19 vaccine and other vaccines received within one month prior to any dose of Moderna COVID-19 vaccine were reported as unknown.   This case was linked to MOD-2022-542869 (Patient Link).
After patient got vaccinated. He was sitting down then stood up and felt faint, fell and hit his head on the concrete wall. He stated he tried to use his hand for balanced but missed and fell. Paramedics responded. Pt has laceration on right side of his forehead. Briefly out for a few seconds. Vitals are stable. Blood sugar normal.  Paramedics stated he will need stitches. Paramedics advised him to go to hospital to get stitches but patient said he is okay. Pt stated his girlfriend will take him home.
9/24/10 Fever and aches. 9/25/10 Skin rash over 25% of body hoarseness, dizziness, fast heart beat. Severe swelling, redness and muscle aches in injection arm.
"I did not feel well for 2 days"; Chills; "I had a moment where a sharp pain ran through my brain briefly and I got a headache it was a; could not sleep; urinated all night about every hour in the night; elevated temperature; loss of energy; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), HEADACHE ("I had a moment where a sharp pain ran through my brain briefly and I got a headache it was a), INSOMNIA (could not sleep), POLLAKIURIA (urinated all night about every hour in the night) and PYREXIA (elevated temperature) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concurrent medical conditions included No adverse event and No adverse event. Concomitant products included DULOXETINE, FISH OIL, ROSUVASTATIN, VITAMIN D3 and MULTIVITAMIN & MINERAL.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced CHILLS (Chills), HEADACHE ("I had a moment where a sharp pain ran through my brain briefly and I got a headache it was a), INSOMNIA (could not sleep), POLLAKIURIA (urinated all night about every hour in the night), PYREXIA (elevated temperature) and ASTHENIA (loss of energy). On an unknown date, the patient experienced MALAISE ("I did not feel well for 2 days"). On 07-Apr-2021, CHILLS (Chills), INSOMNIA (could not sleep), POLLAKIURIA (urinated all night about every hour in the night), PYREXIA (elevated temperature) and ASTHENIA (loss of energy) outcome was unknown. At the time of the report, HEADACHE ("I had a moment where a sharp pain ran through my brain briefly and I got a headache it was a) and MALAISE ("I did not feel well for 2 days") outcome was unknown. Not Provided          Treatment information were not provided.    Reporter did not allow further contact
Pt received 2nd dose 7days after receiving initial dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Pt received 2nd dose 7days after receiving initial dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Pt received 2nd dose 7days after receiving initial dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Pt received 2nd dose 7days after receiving initial dose) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.
6/23 ED visit 14-year-old male who presents to the emergency department 6 days status post Covid vaccine #2 who has had persistent fever, up to 105 °F, with some vomiting and nonspecific rash to his arms today.  Work-up initially showed a questionable pulmonary nodule versus infiltrate which CAT scan later shows as a likely hamartoma, likely incidental to his fever.  Work-up showed slight leukopenia, neutrophilia and mild elevation of his cardiac enzyme.  I discussed the case with both my attending physician, our hospitalist pediatrician Doctor T., and the recommendation was to get advice from hospitalist.  I discussed the case with Doctor A. hospitalist on-call, gave him all of the pertinent information including all vitals, lab assessment, EKG, chest x-ray and CT scan findings.  His impression is that this is likely post vaccine myocarditis.  Because the patient has no cardiomegaly, pericardial effusion, normal EKG and feels essentially asymptomatic at this time the patient and his family was given the option of close follow-up tomorrow for repeat troponin and NSAIDs versus transfer to hospital.  Risk/benefits/alternatives were discussed with the patient family and ultimately they would like to treat as an outpatient and come back tomorrow for repeat troponin testing.  6/24  14-year-old male with no chronic illnesses presenting to the emergency department with a worsening rash to the palms of his hands and soles times this morning. Per mother, patient was seen in the emergency department yesterday for generalized body aches, intermittent fever as high as 105 °F, vomiting and localized rash to bilateral forearms.  Patient was diagnosed with fever and myocarditis.  Mother states symptoms started after receiving a second dose of COVID - 19 vaccine approximately 1 week ago.  No diarrhea or shortness of breath.
Pain and swelling of joints related to knuckles of both hands and right anterior ankle; no injury to either of these sites.
Pt presented to clinic on 4/12/2021 c/o rash.  Pt reports that symptoms started the evening she received the vaccine as a small rash on her right lower arm.  Pt states that it has progressed.  Upon assessment, pt has a rash on her scalp, neck, back legs, and in her ears.
Covid shot Pfizer was administered 2 doses to 11yo 7 month . Invalid dob of birth was reported. Patient's parent sign document with invalid dob (var form and covid card) for dob , however patient's correct dob is . no adverse reactions have been reported. They are currently out of the country. We spoke to the mom and verified correct dob verbally to be  . second dose administered 06/08/2021
Patient reports 1-3 days after the flu shot in the left upper extremity she noticed decreased range of motion and pain. Symptoms have persisted and she was seen in the office on 12/9/19. No erythema, edema or rashes. The pain is diffuse in the upper left extremity especially the bicep and triceps. No numbness or tingling. Physical exam showed 3/5 strength in upper left extremity with abduction and adduction against resistance. + spasm palpated over insertion of L triceps. After examining her I suspect that the patient has adhesive capsulitis and that it is just a coincidence that her left upper extremity symptoms started around the same time. She requested that I report her case just to be safe.
I gave Covid vaccine shot to under age minors 4 yrs old discovered it when I wanted to input in the tablet and did not except patient due to under age and wrong birthday on this consent sign by the parent. He did not eligible to receive it.